CAS#117527-50-1|4-{[(2R,3S)-1-{[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-2-(benzoyloxy)-3,7-dihydrogenio-1,9-dihydroxy-10,14,17,17-tetramethyl -11-oxo-6-oxatetracyclo [11.3.1.0^{3,10} .0^{4,7}] heptadec-13-en-15-il] oxy} -1-oxo-3-phenyl-3- (fenilformamido) propan-2-il] oxy-oxy-ho-oxo-oxy-oxo-oxo-oxo-3-- Asid

Non pwodwi	4-{[(2R,3S)-1-{[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-2-(benzoyloxy)-3,7-dihydrogenio-1,9-dihydroxy-10,14,17,17-tetramethyl -11-oxo-6-oxatetracyclo [11.3.1.0^{3,10} .0^{4,7}] heptadec-13-en-15-il] oxy} -1-oxo-3-phenyl-3- (fenilformamido) propan-2-il] oxy-oxy-ho-oxo-oxy-oxo-oxo-oxo-3-- asid	Fòmil estrikti	​
CAS No.	117527-50-1	Pwa molekilè	953.9789
Aparisyon	Solid	Pwen k ap fonn	>153oc (Dec.)
Asay	98%	Pwen bouyi	1026.9 ± 65.0 degre (prevwa)
Fòmil	C51H55NO17	Pakèt	5mg; 10mg; 25mg

 

Aplikasyon

 

• Paclitaxel succinate te itilize kòm yon reyaktif pou preparasyon an nan hydrogelators molekilè yo dwe itilize kòm sistèm livrezon lokal yo pou chimyoterapi.

 

Anbake

 

 

 

Baj popilè: CAS#117527-50-1|4-{[(2r,3s)-1-{[(1s,2s,3r,4s,7r,9s,10s,12r,15s)-4,12-bis(acetyloxy)-2-(benzoyloxy)-3,7-dihydrogenio-1,9-dihydroxy-10,14,17,17-tetramethyl -11-oxo-6-oxatetracyclo [11.3.1.0^{3,10} .0^{4,7}] heptadec-13-en-15-il] oxy} -1-oxo-3-phenyl-3- (fenilformamido) propan-2-il] oxy-oxy-ho-oxo-oxy-oxo-oxo-oxo-3-- Asid, Lachin CAS#117527-50-1|4-{[(2r,3s)-1-{[(1s,2s,3r,4s,7r,9s,10s,12r,15s)-4,12-bis(acetyloxy)-2-(benzoyloxy)-3,7-dihydrogenio-1,9-dihydroxy-10,14,17,17-tetramethyl -11-oxo-6-oxatetracyclo [11.3.1.0^{3,10} .0^{4,7}] heptadec-13-en-15-il] oxy} -1-oxo-3-phenyl-3- (fenilformamido) propan-2-il] oxy-oxy-ho-oxo-oxy-oxo-oxo-oxo-3-- Konpayi fabrikasyon asid, founisè, faktori